[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …

J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

[HTML][HTML] Stem Cell Therapy in Critical Limb Ischemia

M Jeyaraman, S Nagarajan, N Maffulli… - Cureus, 2023 - ncbi.nlm.nih.gov
Critical limb ischemia (CLI), a serious outcome of peripheral artery disease, is frequently
associated with morbid outcomes. The available treatment modalities do not provide …

The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk

C Cimminiello, S Kownator, JC Wautrecht… - Internal and emergency …, 2011 - Springer
Few studies are available with sufficient sample size to accurately describe the prevalence
of low ankle-brachial index (ABI) in patients at 'non-high'cardiovascular (CV) risk. The aim of …

Overview and comparison of contemporary SVS, AHA, and ESVS guidelines for the management of patients with intermittent claudication

LT Tan, KM McDermott, CW Hicks - Seminars in Vascular Surgery, 2024 - Elsevier
Intermittent claudication (IC) is a phenotype of peripheral artery disease (PAD) that is
characterized by pain in the lower extremity muscles during activity that is relieved by rest …

Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT

LB Piller, LM Simpson, S Baraniuk, GB Habib… - Journal of general …, 2014 - Springer
Background Hypertension is a major risk factor for peripheral artery disease (PAD). Little is
known about relative efficacy of antihypertensive treatments for preventing PAD. Objectives …

Blood pressure levels at the time of percutaneous coronary revascularization and risk of coronary in-stent restenosis

G Tocci, E Barbato, R Coluccia… - American Journal of …, 2016 - academic.oup.com
BACKGROUND High blood pressure (BP) levels expose patients treated with percutaneous
coronary interventions (PCI) to very high risk of 10-year cardiovascular morbidity and …

Collagen-binding nanoparticles for extracellular anti-inflammatory peptide delivery decrease platelet activation, promote endothelial migration, and suppress …

J McMasters, A Panitch - Acta biomaterialia, 2017 - Elsevier
Peripheral artery disease is an atherosclerotic stenosis in the peripheral vasculature that is
typically treated via percutaneous transluminal angioplasty. Deployment of the angioplasty …

Individual blood pressure responses to walking and resistance exercise in peripheral artery disease patients: Are the mean values describing what is happening?

AHRA Lima, AS Miranda, MA Correia… - Journal of Vascular …, 2015 - Elsevier
Objective The aim of this study was to analyze the average and individual blood pressure
responses to walking and resistance exercise in patients with peripheral artery disease …

Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of …

G Sanna, D Alesso, M Mediati, C Cimminiello… - BMC Cardiovascular …, 2011 - Springer
Background The PANDORA study has recently examined the prevalence of low ankle
brachial index (ABI) in subjects with moderate risk of cardiovascular disease. This sub …

Screening for peripheral arterial disease and carotid artery disease in patients with abdominal aortic aneurysm

C Gray, P Goodman, P Cullen, SA Badger… - …, 2016 - journals.sagepub.com
Screening for concomitant atherosclerotic disease is important in cardiovascular risk
reduction. This study assessed the prevalence of carotid artery disease (CAD) and …